Taconis W K, van Rijssel T G
J Bone Joint Surg Br. 1985 Jan;67(1):111-6. doi: 10.1302/0301-620X.67B1.2981883.
A study was made of the clinical course of 102 cases of fibrosarcoma of long bones. Of these, 55 were predominantly fibroblastic or pure fibrosarcomata while 47 contained extensive areas resembling so-called malignant fibrous histiocytoma (MFH). Treatment was similar in the two groups, and the five-year survival was the same, 34%, in both groups. Lung metastases developed in 63% of the fibroblastic sarcomata and 59% of the MFH-like tumours. Our study indicates that there is no significant difference in behaviour in fibrosarcoma with or without marked MFH features. The histological grading of both groups of fibrosarcomata together was of prognostic value; five-year survival was 64% in 14 Grade I tumours, 41% in 32 Grade II tumours and 23% in 56 Grade III tumours.
对102例长骨纤维肉瘤的临床病程进行了研究。其中,55例主要为纤维母细胞性或纯纤维肉瘤,而47例含有广泛类似所谓恶性纤维组织细胞瘤(MFH)的区域。两组的治疗方法相似,两组的五年生存率相同,均为34%。纤维母细胞肉瘤的63%和类似MFH的肿瘤的59%发生了肺转移。我们的研究表明,具有或不具有明显MFH特征在纤维肉瘤的行为上没有显著差异。两组纤维肉瘤的组织学分级具有预后价值;14例I级肿瘤的五年生存率为64%,32例II级肿瘤为41%,56例III级肿瘤为23%。